首页> 外国专利> Predicting prostate cancer risk of progression with multiparametric magnetic resonance imaging using machine learning and peritumoral radiomics

Predicting prostate cancer risk of progression with multiparametric magnetic resonance imaging using machine learning and peritumoral radiomics

机译:使用机器学习和Peritumoral adiomics预测多射磁共振成像的前列腺癌的风险

摘要

Embodiments facilitate stratification of a patient according to prostate cancer (PCa) risk. A first set of embodiments relates to training of a machine learning classifier to compute a probability that a patient has a low-risk of PCa progression based on intratumoral radiomic features and peritumoral radiomic features extracted from multi-parametric magnetic resonance imaging (mpMRI) images. A second set of embodiments relates to classifying a patient as low-risk of PCa progression, or high-risk of PCa progression, based on radiomic features extracted from mpMRI imagery of the patient.
机译:实施方案促进根据前列腺癌(PCA)风险的患者的分层。第一组实施例涉及对机器学习分类器的训练,以计算患者基于从多参数磁共振成像(MPMRI)图像中提取的型危险因子辐射瘤特征和腹部射出物特征具有低风险的PCA进展。第二组实施方案涉及基于从患者的MPMRI图像提取的辐射瘤特征对患者作为PCA进展的低风险或PCA进展的高风险。

著录项

  • 公开/公告号US11011265B2

    专利类型

  • 公开/公告日2021-05-18

    原文格式PDF

  • 申请/专利权人 CASE WESTERN RESERVE UNIVERSITY;

    申请/专利号US201916395904

  • 申请日2019-04-26

  • 分类号G16H30/40;G06T7;G06T7/11;G16H50/20;A61B5/055;A61B5;A61N5/10;G06K9/62;G16H50/30;

  • 国家 US

  • 入库时间 2022-08-24 18:43:08

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号